Skip to main content
Clinical Trials/CTRI/2018/07/014963
CTRI/2018/07/014963Not yet recruitingNot Applicable

A single centre retrospective study of survival, prognostic factors and treatment in colorectal cancer patients at tertiary care centre in India.

max healthcare pvt ltd1 site in 1 country95 target enrollmentStarted: July 19, 2018Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
95
Locations
1
Primary Endpoint
1.Estimation of overall survival (OS) rate and median overall survival of colorectal cancer treated patients

Study Overview

Brief Summary

There is limited number of studies regarding theprevalence, awareness in Indian subjects. So our study will add to theavailable epidemiological data and also analyse the factors impacting thesurvival of patents in Indian colorectal patients.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 90.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Histologically proven colorectal carcinoma.

Exclusion Criteria

  • Patient clinical data not available.

Outcomes

Primary Outcomes

1.Estimation of overall survival (OS) rate and median overall survival of colorectal cancer treated patients

Time Frame: 1 month

Secondary Outcomes

  • 1.Estimation of all treatment response in colorectal cancer patients.(2.Estimation of survival in different prognostic factor)

Investigators

Sponsor
max healthcare pvt ltd
Sponsor Class
Private hospital/clinic

Study Sites (1)

Loading locations...

Similar Trials